[Osteomalacia from phosphate-binding substances (author's transl)].
A case is told with osseous fractures occurred during uremia in a periodically dialyzed man treated with phosphate-binding substances in excessive doses. The healing time is studied to value the effectiveness of normalized phosphatemia and the vitamin D treatment necessity.
D000328:Adult; D000536:Aluminum Hydroxide / Q000009:adverse effects / Q000627:therapeutic use; D000728:Androgens / Q000627:therapeutic use; D001665:Binding Sites; D002614:Chelating Agents / Q000009:adverse effects*; D006801:Humans; D007501:Iron / Q000627:therapeutic use; D008274:Magnesium / Q000627:therapeutic use; D008297:Male; D010018:Osteomalacia / Q000139:chemically induced*; D010758:Phosphorus / Q000097:blood*; D006435:Renal Dialysis; D014511:Uremia / Q000097:blood / Q000150:complications / Q000188:drug therapy*
D000728:Androgens; D002614:Chelating Agents; D010758:Phosphorus; D000536:Aluminum Hydroxide; D007501:Iron; D008274:Magnesium
Osteomalacia grave in uremico in trattamento con chelanti del fosforo in dosi eccessive